Toregem Bio Pharma Co., Ltd. announced that it has received ¥10 million in funding from Kyogin Lease & Capital Co., Ltd., The Bank of Kyoto, Ltd.
April 29, 2021
Share
Toregem Bio Pharma Co., Ltd. announced that it has received ¥10,000,000 in a round of funding on April 30, 2021. The transaction included participation from Kyogin Kagayaku Mirai Ouen Fund No. 2, a fund co-managed by Kyogin Lease & Capital Co., Ltd. and The Bank of Kyoto, Ltd. (TSE:8369).
Kyoto Financial Group Inc is a Japan-based company mainly engage in the management and administration of banks and other companies that may be made subsidiaries under the Banking Law, as well as other businesses incidental and related thereto. The Kyoto Bank Group is principally engaged in banking business and other businesses related to financial services, including leasing, credit card, and securities businesses. The head office and other branches of Kyoto Bank conduct deposit, lending, trading of commodity securities, investment in securities, domestic exchange, foreign exchange, and trust businesses, and are positioned as the core operations of the group. In addition, through its consolidated subsidiaries, the Company is engaged in the provision of real estate management and leasing services, management of electronic commerce (EC) malls, credit guarantee services, leasing services, investment services, credit card services, economic research, and business consultation services.
BK OF KYOTO 
